Effects of Octreotide in Small Cell Lung Cancer
Author Information
Author(s): V.M. Macaulay, I.E. Smith, M.J. Everard, J.D. Teale, J.-C. Reubi, J.L. Millar
Primary Institution: Royal Marsden Hospital and Institute of Cancer Research
Hypothesis
Does octreotide have an anti-tumor effect in small cell lung cancer patients?
Conclusion
Octreotide treatment showed no significant anti-tumor activity in small cell lung cancer patients.
Supporting Evidence
- Octreotide was well tolerated by most patients.
- Serum insulin-like growth factor-I levels were suppressed during treatment.
- None of the patients showed significant tumor response to octreotide.
Takeaway
Doctors tested a medicine called octreotide to see if it could help people with a type of lung cancer, but it didn't work as they hoped.
Methodology
The study involved treating 20 patients with octreotide and measuring tumor markers and growth inhibition in cell lines.
Limitations
The study had a small sample size and did not show significant clinical benefits.
Participant Demographics
20 patients with small cell lung cancer, including 6 previously untreated and 14 relapsed after chemotherapy.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website